REGN3048
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REGN3048, covering 2019-02-01 to 2019-02-01. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051 [Phase 1]